Description
A selective, cell-permeable, reversible inhibitor of MKLP-2 (IC50s = 0.83-1.35 µM); treatment with 10-50 µM results in binucleated cells, perturbing relocation of Aurora B kinase and survivin to the central spindle in anaphase cells without affecting microtubule polymerization